Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Access to healthcare

Indian hepatitis C drug patent decision shakes public health community

Editor's pick
EATG / The Lancet
6 June 2016
Hepatitis C treatment

France to provide universal access to hepatitis C treatment

News
2 June 2016
Hepatitis C treatment

Patients who pay £1,000 for life-saving drugs online that would cost NHS £35,000: More and more are doing it - but doctors warn it's a big risk

Editor's pick
Daily Mail
1 June 2016
Access to healthcare

Burden of pricey hepatitis C drugs heaviest in eastern Europe

Editor's pick
Reuters
1 June 2016
Access to healthcare

Large global range of prices for hepatitis C medicines raises concerns about affordability

Editor's pick
Eurekalert Inf Dis
1 June 2016
Hepatitis C treatment

Washington Ordered to Cover Hepatitis C Drugs During Lawsuit

Editor's pick
Bloomberg
31 May 2016
Hepatitis C treatment

Philippines FDA warns against fake Hepatitis C medicines

Editor's pick
GMA News
31 May 2016
Hepatitis C treatment

Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England

News
25 May 2016
Hepatitis C treatment

Next-generation HCV treatments should benefit challenging patient groups

Editor's pick
Digestive Disease Week blog
23 May 2016
Hepatitis C treatment

The Hepatitis C Trust is considering seeking a judicial review of NHS England’s decision to ration access to hepatitis C treatment

Editor's pick
Hepatitis C Trust
18 May 2016
Hepatitis C treatment

Does having HIV affect response to hepatitis C treatment?

News
16 May 2016
Hepatitis C treatment

WHO issues new hepatitis C guidelines, EASL guidelines update forthcoming in September

News
12 May 2016
Hepatitis C treatment

Philip Christopher Baldwin: “We need better access to treatment for gay men living with HIV and Hep C”

Editor's pick
Gay Times
11 May 2016
Hepatitis C treatment

Covering Costly HCV Tx: Who Makes that Call?

Editor's pick
MedPage Today HIV/AIDS
11 May 2016
Hepatitis C treatment

It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments

Editor's pick
American Journal of Managed Care
10 May 2016
Finance & funding

Study: Cheaper to cure hepatitis C sooner than later

Editor's pick
UPI.com
10 May 2016
Hepatitis C treatment

A Way Out of the Dismal Arithmetic of Hepatitis C Treatment

Editor's pick
American Journal of Managed Care
10 May 2016
Access to healthcare

Gilead's $1000 hepatitis C pill gets patent in India

Editor's pick
Times of India
10 May 2016
Hepatitis C treatment

Hepatitis C kills more people than any other infectious disease in US, CDC says

News
6 May 2016
Hepatitis C treatment

Hepatitis C therapy improves quality of life for people who inject drugs, but reinfection risk remains

News
6 May 2016
Pharmaceutical industry

Sky-high price of hepatitis C drug produces profits for lawmakers

Editor's pick
Center for Responsive Politics
5 May 2016
Hepatitis C treatment

Antiviral therapies give Hepatitis C cirrhosis patients similar life expectancy as general population

Editor's pick
Eurekalert Medicine & Health
5 May 2016
Hepatitis C treatment

First Canadian Study Demonstrates Potential to Remove Patients from Active Liver Transplant List After Curing Hepatitis C

Editor's pick
Lawson Health Research Institute press release
3 May 2016
Pharmaceutical industry

'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Editor's pick
Fierce Pharma
3 May 2016